首页> 中文期刊> 《中国医学创新》 >血浆脂联素检测在冠心病患者中的临床意义

血浆脂联素检测在冠心病患者中的临床意义

         

摘要

Objective:To investigate clinical significance of the plasma adiponectin(APN)level in patients with coronary heart disease,and role in the development of coronary heart disease.Method:80 cases of patients with coronary heart disease,stable angina pectoris group of 45 cases,unstable angina group of 35 cases,30 cases of normal healthy people as a control group,plasma APN level,LDL-C,HDL-C were detected,and the results were analyzed.Result:In patients with coronary heart disease APN levels were significantly lower than those in the control group,the difference was statistically significant(P<0.05);unstable angina group APN level was lower than the stable angina group(P<0.05). Conclusion:Adiponectin may be a protective factor for coronary heart disease,and is negatively correlated with the development of coronary heart disease,also provide the clinical basis for the diagnosis of coronary heart disease.%  目的:探讨血浆脂联素(APN)水平在冠心病患者中的临床意义,以及其在冠心病发生、发展中的作用。方法:选取确诊为冠心病患者共80例,其中稳定型心绞痛组45例,不稳定型心绞痛组35例,并且选取30例正常健康人作为对照组,检测血浆APN水平,同时检测LDL-C、HDL-C,并对检测结果进行分析。结果:冠心病患者APN水平明显低于对照组,两组比较差异有统计学意义(P<0.05);不稳定型心绞痛组APN水平低于稳定型心绞痛组(P<0.05)。结论:脂连素可能为冠心病的一个保护因子,其与冠心病的发生发展呈负相关,为诊断冠心病提供了临床依据。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号